Dr. Greg Smith has held a variety of positions relating to the manufacture, testing, regulation and technology transfer of biological and pharmaceutical therapeutic goods.
He has had more than 10 years experience with the Australian Therapeutic Goods Administration (TGA) and the associated laboratories (TGAL). This included roles as the Head of the TGAL Virology Unit and as a Senior GMP auditor. He has also worked in human influenza vaccine process development at CSL Ltd and for Pfizer Animal Health in Australia as the leader of the Viral Vaccine Sub-Team of the Bioprocess Improvement Group.
Greg has also served as the National Regulatory Affairs Manager with the Australian Red Cross Bl...